OverviewChartNewsTraderScreen

Soc. Generale Knock-Out QIA 20.09.../  DE000SW8ZAP9  /

Frankfurt Zert./SG
5/24/2024  9:48:10 PM Chg.-0.450 Bid9:59:46 PM Ask- Underlying Strike price Expiration date Option type
7.050EUR -6.00% 7.000
Bid Size: 1,000		 -
Ask Size: -		 QIAGEN NV EO... - EUR 9/20/2024 Call
GlobeNewswire 5/22 deepull appoints Didier Deltort to its Board of Directors
GlobeNewswire 5/14 QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical devic...
GlobeNewswire 5/13 QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accura...
GlobeNewswire 5/7 QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics
GlobeNewswire 5/7 Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire 5/7 Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire 5/2 QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inher...
GlobeNewswire 4/29 QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance
GlobeNewswire 4/25 deepull unveils 1 hour, direct-from-blood multiplex PCR test for 95% of sepsis-causing pathogens at ...
GlobeNewswire 4/24 QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and comba...
GlobeNewswire 4/18 deepull appoints Kimberle Chapin, MD, as Chief Medical Officer and Wade Stevenson as Chief Marketing...
GlobeNewswire 4/9 QIAGEN N.V. to release results for Q1 2024 and hold webcast
GlobeNewswire 4/3 QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Ann...
GlobeNewswire 3/25 QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration a...
GlobeNewswire 3/18 QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosi...
GlobeNewswire 3/11 QIAGEN announces Form 20-F annual report filing for 2023 results
GlobeNewswire 2/27 QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery
GlobeNewswire 2/27 QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Plati...
GlobeNewswire 2/15 QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Plati...
GlobeNewswire 2/6 QIAGEN exceeds outlook for Q4 2023, led by 8% CER sales growth in non-COVID products and improved op...
TeleTrader 2/6 Europe higher at close, economic prints in spotlight
TeleTrader 1/29 Europe opens mixed ahead of data
GlobeNewswire 1/25 QIAGEN announces partnership with Penn State University to advance microbiome sciences
GlobeNewswire 1/18 QIAGEN announces details for completion of synthetic share repurchase of up to approximately $300 mi...
GlobeNewswire 1/11 QIAGEN N.V. to release results for Q4 2023 and hold webcast